<DOC>
	<DOCNO>NCT01232049</DOCNO>
	<brief_summary>This study design evaluate pharmacokinetic drug interaction safety Pitavastatin Valsartan healthy male subject</brief_summary>
	<brief_title>Drug Interaction Safety Between Pitavastatin Valsartan ( CWP-PTV-101 )</brief_title>
	<detailed_description />
	<mesh_term>Pitavastatin</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<criteria>Adult male age 20 50 year screen . No significant congenital/chronic disease . No symptoms physical examination . Appropriate subject determine past medical history , laboratory test , serology urinalysis . Be able understand objective , method study , characteristic investigational drug , comply requirement study . Subject must provide write informed consent prior study participation . History presence liver , kidney , nervous system disease , respiratory disorder , endocrinological disorder , hematooncologic , cardiovascular psychiatric cognitive disorder . History gastrointestinal disorder ( bleed , ulceration , hemorrhoid , pile ) disorder absorption , distribution , metabolism , excretion . History known hypersensitivity drug include valsartan pitavastatin .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>healthy volunteer</keyword>
</DOC>